POLATUZUMAB-VEDOTIN+BENDAMUSTIN+RITUXIMAB AS SALVAGE AND BRIDGING THERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Although diffuse large B-cell lymphoma (DLBCL) represents a paradigm of highly curative disease with a complete remission (CR) rate of ≈ 60%–70% in an upfront setting, the remaining 30%–40% of patients present a relapse/refractory setting. These population are highly critical and amended for salvage treatment approach. Novel appro...
By Ivan Petković, Marija Elez, Aleksandar Popović, Slavica Stojnev, Irena Conic, Miljana Džunić, Dane Krtinić
Nivolumab treatment in a mucosal melanoma patient with pre-existing systemic lupus erythematosus: A case report with literature review
Introduction. Systemic lupus erythematosus (SLE) represents a multisystemic disease characterized by antibody production, complement activation, and immune complexes deposition. Certain types of malignancies occur more often, and conversely, some of them occur less often in SLE patients. Mucosal melanoma of the anorectal region represents a rare fo...
By Aleksandar Popović, Ivan Petković, Andrija Rančić, Aleksandra Dimitrijević, Vesna Brzački, Stefan Stankov, Andrija Jović, Sonja Stojanović
Clinical and dermoscopic features of lentigo maligna
Introduction/Aim. Lentigo maligna (LM) represents an in situ melanoma that develops on chronically photo-damaged skin. Clinical diagnosis of LM is often difficult, even for experienced dermatologists. The aim of the study was to analyze the clinical and dermoscopic features of patients with pathohistologically verified lentigo maligna (LM) and to d...
By Danica Tiodorović, Danijela Popović, Slađana Cekić, Milica Radić, Aleksandar Popović, Nataša Vidović, Andrija Jović
Nodal and extranodal peripheral T/NK-cell neoplasms: Current aspects
...
By Ivan Petković, Aleksandar Popović, Miljana Džunić, Ivica Pejčić